UCB Accesses Brazilian Market by Acquiring Majority Stake in Meizler Biopharma
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 6 (Table of Contents)
Published: 8 Jun-2012
DOI: 10.3833/pdr.v2012.i6.1751 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
UCB Pharma has agreed to acquire a 51% majority stake in privately held Meizler Biopharma in order to make a direct entry into the Brazilian pharmaceutical market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS